Skip to main content
bioRxiv

Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling

Publication ,  Preprint
Chen, G; Luo, H; Luo, X; Singh, S; Ramirez, J; James, M; Mathew, J; Berger, M; Eroglu, C; Ji, R-R
2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

DOI

Publication Date

2022
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, G., Luo, H., Luo, X., Singh, S., Ramirez, J., James, M., … Ji, R.-R. (2022). Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling. bioRxiv. https://doi.org/10.1101/2022.03.28.486142
Chen, Gang, Hao Luo, Xin Luo, Sandeep Singh, Juan Ramirez, Michael James, Joseph Mathew, Miles Berger, Cagla Eroglu, and Ru-Rong Ji. “Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling.” BioRxiv, 2022. https://doi.org/10.1101/2022.03.28.486142.
Chen G, Luo H, Luo X, Singh S, Ramirez J, James M, et al. Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling. bioRxiv. 2022.
Chen, Gang, et al. “Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling.” BioRxiv, 2022. Epmc, doi:10.1101/2022.03.28.486142.
Chen G, Luo H, Luo X, Singh S, Ramirez J, James M, Mathew J, Berger M, Eroglu C, Ji R-R. Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling. bioRxiv. 2022.

DOI

Publication Date

2022